At the end of July, MyAge Co-Director, Professor Carolyn Greig, retires from the University of Birmingham, and from her position on the MyAge management group. We take a moment here to thank Carolyn warmly for her outstanding service to the network and look back over the past two years as Co-Director. We are also delighted to announce that Helen McGettrick, Professor of Inflammation and Vascular Biology at the University of Birmingham, has agreed to join the MyAge management group as Carolyn steps back.
Carolyn, how do your research interests connect you to MyAge and muscle resilience?
I’ve always been interested in helping older people to stay physically independent for long as possible, by developing interventions to improve muscle health and optimise functional ability – in other words, the ability to carry out everyday tasks, like getting out of a chair, or carrying the shopping home.
I’ve worked with very diverse groups, including older athletes, healthy older individuals, people living with frailty and patient groups for whom a lack of muscle resilience will have health consequences. Over time, my interests have evolved, now encompassing a broader approach to understanding the problems facing older people in low and middle income countries.
Has leading MyAge brought any new perspectives to your research?
Yes, it has been a real positive! My involvement with MyAge has enriched my own research in more ways than anticipated. For example, I have developed an increased interest in a life course approach to healthy ageing. A real highlight was the workshop we conducted with a youth panel from the LifeLab project. The young people brought such valuable and unexpected insights and have helped put my research into a different context.
Where do you think MyAge has added value to the ageing research community?
I think the launch of the MyAge Roadmap was a great achievement for the network and it was our primary output in terms of trying to transform ageing research in the UK. We worked hard to incorporate the views of network members and consulted carefully during the drafting process. We hope that the Roadmap and its accompanying versions (for public outreach, industry and policymakers) will be a useful resource for researchers across UKAN. The UK Ageing Networks were tasked with building interdisciplinary networks: There were challenges, for example, – we realised early on that we needed to strengthen our engagement with social scientists. We have had some really great support from social scientists to help frame the research questions in the Roadmap so that the document can engage people with a wide range of expertise and perspectives.
What are the next steps for MyAge?
The UK Ageing networks have received a 12-month extension. MyAge will use the time to focus on some of the recommendations in the Roadmap, for example by building international partnerships – we lead a UKRI Global Partnership Award focusing on the USA and Canada – and by developong stronger links with industry.
Free time is on the horizon – would you like to share any plans for the future?
I have travel plans, including a trip to South Korea and Japan in the autumn. I have served on research ethics committees as an academic researcher, and might continue to do so in the future as a lay member. I would also like to do some voluntary work with older people, and improve my French – boredom is highly unlikely.
The last two years working with MyAge have been a very happy and productive time. Everything we did, worked out well, and I met some great people. I would also like to thank our public contributors, especially Elizabeth Robinson, Gillian Richards and Ian Clarke, who did invaluable work helping shape the MyAge Roadmap. It has been a pleasure.
Helen, welcome to the MyAge management group! You lead the Inflammation, Vascular and Bone research group at the University of Birmingham. How does muscle resilience intersect with your research interests?
My team focuses on what goes wrong in immune-mediated inflammatory diseases such as rheumatoid arthritis, cardiovascular disease, inflammatory bowel disease; certain musculoskeletal disorders and some cancers, as well as the effects of ageing on the immune system. We study the tissue (stromal) microenvironment in different tissues, including the muscle. I am part of team, led by Dr Thomas Jackson, which has recently received a large Wellcome Leap award under the ‘Dynamic Resilience’ programme. We are going to study biological signals (biomarkers) to see if they can predict who will recover well after a stress event, like surgery (i.e., are resilient) and who may need additional help, such as prehabilitation (protective steps taken in advance to improve health and fitness and prepare for a good rehabilitation). We will also consider other kinds of stress events or challenges, like injury, or physiological processes like the menopause.
A recent example of our research in bone diseases is here.
What are your ambitions for MyAge?
I would like to see MyAge embedded in UK research policy as an established network and conduit to ensure cross-fertilisation of ideas and expertise across ageing research and other disciplines. I’m a big advocate of mentoring to help support early career researchers’ progression towards independence through funding and impact of their research. This is particularly important in this current funding landscape, which is challenging at all career levels. I think MyAge can play an important role supporting the next generation of interdisciplinary researchers.

